Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation.
about
Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalkPrimary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapiesPathogenesis and clinical spectrum of primary sclerosing cholangitis.Current status of therapy in autoimmune liver diseaseRole of the microbiota and antibiotics in primary sclerosing cholangitis.Searching for Bacterial Biofilm in Recurrent Cholangitis in Primary Sclerosing Cholangitis: A Case Presentation and Introduction of an Unexplored Disease Mechanism.
P2860
Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Azithromycin may reduce choles ...... and serendipitous observation.
@en
Azithromycin may reduce choles ...... and serendipitous observation.
@nl
type
label
Azithromycin may reduce choles ...... and serendipitous observation.
@en
Azithromycin may reduce choles ...... and serendipitous observation.
@nl
prefLabel
Azithromycin may reduce choles ...... and serendipitous observation.
@en
Azithromycin may reduce choles ...... and serendipitous observation.
@nl
P2093
P2860
P1476
Azithromycin may reduce choles ...... and serendipitous observation.
@en
P2093
P2860
P304
P356
10.1177/039463200702000423
P577
2007-10-01T00:00:00Z